Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Revision of interpretation criteria of the INNO-LiPA HBV genotyping assay.

Doutreloigne J, Van Hecke E, Mercier M, Laperche S.

J Clin Microbiol. 2011 Sep;49(9):3446. doi: 10.1128/JCM.00815-11. No abstract available.


Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.

Niesters HG, Zoulim F, Pichoud C, Buti M, Shapiro F, D'Heuvaert N, Celis L, Doutreloigne J, Sablon E.

Antimicrob Agents Chemother. 2010 Mar;54(3):1283-9. doi: 10.1128/AAC.00970-09. Epub 2010 Jan 11.


Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.

Libbrecht E, Doutreloigne J, Van De Velde H, Yuen MF, Lai CL, Shapiro F, Sablon E.

J Clin Microbiol. 2007 Dec;45(12):3935-41. Epub 2007 Oct 3.


Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.

Yuan HJ, Ka-Ho Wong D, Doutreloigne J, Sablon E, Lai CL, Yuen MF.

J Infect. 2007 May;54(5):497-503. Epub 2006 Sep 25.


Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.

Yuan HJ, Yuen MF, Wong DK, Sum SM, Doutreloigne J, Sablon E, Lai CL.

J Clin Microbiol. 2005 Apr;43(4):1594-9.


Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.

Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan HJ, Wong DK, Sum SM, Lai CL.

J Hepatol. 2004 Jul;41(1):119-25.


Prognostic factors in severe exacerbation of chronic hepatitis B.

Yuen MF, Sablon E, Hui CK, Li TM, Yuan HJ, Wong DK, Doutreloigne J, Bogaerts V, Wong BC, Fan ST, Lai CL.

Clin Infect Dis. 2003 Apr 15;36(8):979-84. Epub 2003 Apr 2.


Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.

Yuen MF, Sablon E, Yuan HJ, Hui CK, Wong DK, Doutreloigne J, Wong BC, Chan AO, Lai CL.

J Infect Dis. 2002 Nov 1;186(9):1335-8. Epub 2002 Oct 11.


Supplemental Content

Loading ...
Support Center